Vimarsana
Biggest News Aggregation in the World

Dirk Arnold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Arnold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Arnold Today - Breaking & Trending Today

USA News Group: Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults - Vimarsana News

USA News Group: Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

USA News Group Commentary VANCOUVER, BC, May 28, 2024 /PRNewswire/ -- USA News Group - Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments - Vimarsana News

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech® Inc. , a clinical-stage...

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX) - Vimarsana News

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)

Oncolytics Biotech Inc. Announces the Anal Cancer Cohort of the Goblet Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy - Vimarsana News

Oncolytics Biotech Inc. Announces the Anal Cancer Cohort of the Goblet Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy

Oncolytics Biotech Inc. announced the presentation of positive, interim results from the Phase 1/2 GOBLET study evaluating the combination of pelareorep and atezolizumab in second-line patients with...

Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board - Vimarsana News

Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today...